Jarrett Szczesny - McDermott Will & Emery


Jarrett Szczesny focuses his practice on representing private equity and other investment funds and privately held companies in connection with domestic and cross-border mergers, acquisitions, venture capital investments, restructurings and other transactions. He provides general corporate counseling to portfolio companies and other clients on matters such as corporate governance, employment, financing and incentive equity. Jarrett’s transactional experience spans a variety of industries, including private equity, health care services and manufacturing.


  • Assisted WindRose Health Investors with the sale of Medical Knowledge Group to Court Square Capital Partners; the acquisition of Trumpet Behavioral Health and its subsequent combination with BlueSprig Pediatrics, a KKR portfolio company; the acquisition of Lykan Bioscience and its subsequent combination with RoslinCT, a GHO Capital portfolio company; the sale of Vital Decisions to Evolent Health; its investment in Thirdwave RX; and its majority control investments in Veristat, RevHealth, StateServ, Workplace Options, Collaborative Imaging, BPD Advertising, CardioOne and MyndYou
  • Assisted Amulet Capital Partners with its control investment in Unlock Health, a healthcare marketing and advertising organization, along with numerous add-on transactions
  • Assisted Enhanced Healthcare Partners with its sale of SCA Pharma to The Vistria Group and Excellere Partners and its sale of Syft to Global Healthcare Exchange, a publicly traded company

Show More


  • The Best Lawyers: Ones to Watch in America, Mergers and Acquisitions Law; Leveraged Buyouts and Private Equity Law and Corporate Law, 2021-2024


University of Illinois College of Law, JD, magna cum laude, 2014
Boston University Questrom School of Business, BSBA, summa cum laude, 2010